Nanyang Biologics
PrivateLast Round
M&A
Oct 2, 2025
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nanyang Biologics is a biotechnology company that provides an AI-driven drug discovery and nature-derived therapeutic platform for longevity and disease treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanyang Biologics Comparables
Compare Nanyang Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enveda Biosciences | 81% | |
| Kapoose Creek Bio | 81% | |
| Brightseed | 80% | |
Nanyang Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 2, 2025 | ||||
| Strategic | Jul 16, 2024 |
Key People
Founding team and executive leadership
Nanyang Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mercatus Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 28% QoQ, from 29 to 37 employees.
- Aug 1, 2026
Grew 40% QoQ, from 25 to 35 employees.
Nanyang Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanyang Biologics's valuation, stock price, and market status.